KELLY SPARKMAN: Open Payments
NPI 1972934313 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 6 payments from 3 companies in 2025. Trend: 2023 $489 · 2024 $110 · 2025 $182
Food & beverage: $182
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $128 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
Products named: INGREZZA, AUSTEDO XR, CAPLYTA.
Industry payments across TX — which companies pay providers there.
